Table 1.
Patient Code | BC Subtype | Access Time | Total | ||
---|---|---|---|---|---|
A | B | C | |||
1 | TNBC | 6 | 0 | 0 | 6 |
2 | TNBC | 1 | 2 | 1 | 4 |
3 | TNBC | 0 | 1 | 3 | 4 |
4 | TNBC | 6 | 3 | 3 | 12 |
TNBC total | 13 | 6 | 7 | 26 | |
6 | HER2+ | 1 | 1 | 1 | 3 |
7 | Luminal A | 1 | 1 | 1 | 3 |
8 | Luminal A | 2 | 3 | 0 | 5 |
9 | Luminal A | 1 | 1 | 1 | 3 |
10 | Luminal A | 1 | 0 | 2 | 3 |
11 | Luminal A | 3 | 0 | 0 | 3 |
12 | Luminal A | 2 | 1 | 0 | 3 |
Non-TNBC total | 11 | 7 | 5 | 23 | |
Total | 24 | 13 | 12 | 49 |
BC: breast cancer; TNBC: triple-negative BC; HER2: H uman Epidermal Growth Factor Receptor 2.